Open-house discount contracts for Golimumab biologics, 2025-2032.
The AOK purchasing consortium (AOK-Einkaufs-Genossenschaft) is procuring Golimumab-containing medicinal products through an open-house model for discount contracts covering the period 2025-2032. The tender is divided into multiple lots, each corresponding to a specific pharmaceutical form and dosage. Suppliers must be able to deliver the products to pharmacies across Germany. The open-house procedure allows any qualified supplier to join the contract during the term. The estimated total value is not disclosed, but the contract duration is 7 years.